Related Experiment Video
Updated: Feb 13, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
Standardizing biomarker testing for Canadian patients with advanced lung cancer
Biomarker testing is crucial for advanced non-small cell lung cancer (NSCLC) patients in Canada. This paper defines the minimum standard of care for biomarker testing, including novel targets, to ensure equitable treatment.
Area of Science:
- Oncology
- Molecular Diagnostics
- Genomics
Background:
- Targeted and immune therapies have improved survival for advanced non-small cell lung cancer (NSCLC).
- Biomarker testing is standard for newly diagnosed NSCLC and upon progression after epidermal growth factor receptor (EGFR) inhibitor treatment.
Purpose of the Study:
- To establish evidence-based recommendations for standard-of-care biomarker testing in the Canadian context for advanced NSCLC.
- To define a minimum standard of care for biomarker testing to ensure equitable treatment for all Canadian NSCLC patients.
Main Methods:
- A consensus of Canadian thoracic oncology experts reviewed evidence for biomarker testing.
- Recommendations cover standard targets (EGFR, ALK, ROS1, BRAF V600, PD-L1) at diagnosis and EGFR T790M upon progression.
- Exploratory targets including MET, RET, HER2, NTRK, RAS, and TP53 were considered for future impact.
Main Results:
- The standard of care necessitates the integration of newly available biomarkers.
- National guidelines may struggle to keep pace with rapid technological advancements in biomarker testing.
Conclusions:
- A defined minimum standard of care for biomarker testing in NSCLC is essential for equitable patient treatment in Canada.
- Continuous incorporation of novel biomarkers is critical for optimal patient management.
More Related Videos
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Related Concept Videos
Testing a Claim about Standard Deviation
The hypothesis testing for the claim of population standard deviation (or variance) requires the data and samples to be random and unbiased. The population distribution also must be normal. There is no specific requirement on the sample size as the estimation is based on the chi-square distribution.
As a first step, the hypothesis (null and alternative) concerning the claim about...
Lung Capacity
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Standard Enthalpy of Formation
Standard Electrode Potentials
Measurement: Standard Units